Hirshfeld grants first USPTO director review after Arthrex

04-11-2021

Alex Baldwin

Hirshfeld grants first USPTO director review after Arthrex

Mark Van Scyoc / Shutterstock.com

The acting director of the US Patent and Trademark Office Drew Hirshfeld has agreed for the first time to review a final written decision from the Patent Trial and Appeal Board (PTAB) after being given oversight over the board’s rulings in the Supreme Court’s Arthrex decision.


Arthrex, Samsung, PTAB, Drew Hirshfield, USPTO, patents

WIPR